180 Life Sciences Corp (ATNF) concluded trading on Thursday at a closing price of $1.83, with 63.43 million shares of worth about $116.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.31% during that period and on July 17, 2025 the price saw a gain of about 107.88%. Currently the company’s common shares owned by public are about 5.19M shares, out of which, 2.88M shares are available for trading.
Stock saw a price change of 106.80% in past 5 days and over the past one month there was a price change of 90.63%. Year-to-date (YTD), ATNF shares are showing a performance of -9.85% which increased to 0.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.66 but also hit the highest price of $17.75 during that period. The average intraday trading volume for 180 Life Sciences Corp shares is 116.37K. The stock is currently trading 99.03% above its 20-day simple moving average (SMA20), while that difference is up 82.04% for SMA50 and it goes to 13.65% higher than SMA200.
180 Life Sciences Corp (NASDAQ: ATNF) currently have 5.19M outstanding shares and institutions hold larger chunk of about 0.47% of that.
The stock has a current market capitalization of $11.06M and its 3Y-monthly beta is at 0.21. It has posted earnings per share of -$5.38 in the same period. It has Quick Ratio of 1.02 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATNF, volatility over the week remained 36.66% while standing at 16.98% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on September 15, 2021 offering a Buy rating for the stock and assigned a target price of $11 to it.